Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Cantor Fitzgerald

Generated: November 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,802,142

« Back to Dashboard

Which drugs does patent 8,802,142 protect, and when does it expire?

Patent 8,802,142 protects KEPPRA and is included in one NDA. There has been one Paragraph IV challenge on Keppra.

Protection for KEPPRA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 8,802,142

Title:Pharmaceutical compositions comprising levetiracetam and process for their preparation
Abstract: The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient and 2.0 to 9.0% per weight of disintegrant, 0.0 to 3.0% per weight of gliding agent, 0.5 to 6.0% per weight of binder, and 0.0 to 1.0% per weight of lubricant, with respect to the total weight of the pharmaceutical composition, and to a process for its preparation.
Inventor(s): Deleers; Michel (Linkebeek, BE), Hubert; Jean-Beno t (Haaltert, BE)
Assignee: UCB Pharma, S.A. (Brussels, BE)
Application Number:11/910,167
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Process;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ucb Inc
TABLET;ORAL021035-004Jan 6, 2006ABRXYesYes► Subscribe► SubscribeY
Ucb Inc
TABLET;ORAL021035-001Nov 30, 1999ABRXYesNo► Subscribe► SubscribeY
Ucb Inc
TABLET;ORAL021035-002Nov 30, 1999ABRXYesNo► Subscribe► SubscribeY
Ucb Inc
TABLET;ORAL021035-003Nov 30, 1999ABRXYesNo► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,802,142

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05016189Jul 26, 2005
05016945Aug 4, 2005
PCT Information
PCT FiledJuly 24, 2006PCT Application Number:PCT/EP2006/007260
PCT Publication Date:February 01, 2007PCT Publication Number: WO2007/012439

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Queensland Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus